Antiandrojen (Turkish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Antiandrojen" in Turkish language version.

refsWebsite

Global rank Turkish rank

6doi.org

2^nd place

4^th place

4nih.gov

4^th place

11^th place

3archive.org

6^th place

archive.org

Using Medical Terminology: A Practical Approach. Lippincott Williams & Wilkins. 2006. ss. 977-. ISBN 978-0-7817-4868-1.
"Steroidal Antiandrogens". Hormone Therapy in Breast and Prostate Cancer. Humana Press. 2009. ss. 325-346. doi:10.1007/978-1-59259-152-7_15. ISBN 978-1-60761-471-5.
"Nonsteroidal Antiandrogens". Hormone Therapy in Breast and Prostate Cancer. Humana Press. 2009. ss. 347-368. doi:10.1007/978-1-59259-152-7_16. ISBN 978-1-60761-471-5.

doi.org

"Sex Hormones (Male): Analogs and Antagonists". Encyclopedia of Molecular Cell Biology and Molecular Medicine. 2006. doi:10.1002/3527600906.mcb.200500066. ISBN 3527600906.
"Anti-androgen hormonal therapy for cancer and other diseases". Eur. J. Pharmacol. 866: 172783. Ocak 2020. doi:10.1016/j.ejphar.2019.172783. PMID 31712062.
"Antiandrogen treatments in locally advanced prostate cancer: are they all the same?". J Cancer Res Clin Oncol. 1: S17-26. 2006. doi:10.1007/s00432-006-0133-5. PMID 16845534.
"Androgen deprivation therapy for prostate cancer chemoprevention: current status and future directions for agent development". Urology. 58 (2 Suppl 1): 83-90. 2001. doi:10.1016/s0090-4295(01)01247-x. PMID 11502457. There are several classes of antiandrogens including (1) antigonadotropins (eg, LHRH agonists/antagonists, synthetic estrogens [diethylstilbestrol]); (2) nonsteroidal androgen-receptor antagonists (eg, flutamide, bicalutamide, nilutamide); (3) steroidal agents with mixed actions (eg, cyproterone acetate); (4) adrenal androgen inhibitors (eg, ketoconazole, hydrocortisone); (5) steroidal agents that inhibit androgen biosynthesis (eg, 5α-reductase inhibitors (type II) and dual-acting 5α-reductase inhibitors); [...]
"Steroidal Antiandrogens". Hormone Therapy in Breast and Prostate Cancer. Humana Press. 2009. ss. 325-346. doi:10.1007/978-1-59259-152-7_15. ISBN 978-1-60761-471-5.
"Nonsteroidal Antiandrogens". Hormone Therapy in Breast and Prostate Cancer. Humana Press. 2009. ss. 347-368. doi:10.1007/978-1-59259-152-7_16. ISBN 978-1-60761-471-5.

nih.gov

ncbi.nlm.nih.gov

"Antiandrogens. Mechanisms and paradoxical effects". Ann. Endocrinol. Paris. 50 (3): 50(3):189-99. 1989. PMID 2530930.
"Anti-androgen hormonal therapy for cancer and other diseases". Eur. J. Pharmacol. 866: 172783. Ocak 2020. doi:10.1016/j.ejphar.2019.172783. PMID 31712062.
"Antiandrogen treatments in locally advanced prostate cancer: are they all the same?". J Cancer Res Clin Oncol. 1: S17-26. 2006. doi:10.1007/s00432-006-0133-5. PMID 16845534.
"Androgen deprivation therapy for prostate cancer chemoprevention: current status and future directions for agent development". Urology. 58 (2 Suppl 1): 83-90. 2001. doi:10.1016/s0090-4295(01)01247-x. PMID 11502457. There are several classes of antiandrogens including (1) antigonadotropins (eg, LHRH agonists/antagonists, synthetic estrogens [diethylstilbestrol]); (2) nonsteroidal androgen-receptor antagonists (eg, flutamide, bicalutamide, nilutamide); (3) steroidal agents with mixed actions (eg, cyproterone acetate); (4) adrenal androgen inhibitors (eg, ketoconazole, hydrocortisone); (5) steroidal agents that inhibit androgen biosynthesis (eg, 5α-reductase inhibitors (type II) and dual-acting 5α-reductase inhibitors); [...]